1-11 of 11
Stefano R Tarantolo
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Preliminary Safety, Efficacy, and Molecular Characterization of Emavusertib (CA-4948) in Relapsed/Refractory Acute Myeloid Leukemia Patients

Eric S. Winer, David Sallman, Adolfo De la Fuente Burguera, Amit Verma, Katharina Goetze, Yasmin Abaza, James P. Dugan, Thomas Cluzeau, Eduardo Rodriguez Arboli, Alice Mims, Stefanie Groepper, Itay Zilbershatz, Jane L. Liesveld, Walter Fiedler, Stefano R Tarantolo, Lionel Ades, Nikolaos Papadantonakis, Christoph Schliemann, Gaurav S Choudhary, Maureen Lane, Wanying Zhao, Ashish Jain, Cole Gallagher, Guillermo Garcia-Manero
Journal: Blood
Blood (2024) 144 (Supplement 1): 737.
https://doi.org/10.1182/blood-2024-207953
Published: 2024
Journal Articles

Preliminary Safety, Efficacy and Molecular Characterization in Patients with Higher-Risk Myelodysplastic Syndrome Treated with Single Agent Emavusertib (CA-4948)

Guillermo Garcia-Manero, David Sallman, Stefano R Tarantolo, Amit Verma, Stefanie Groepper, Alice Mims, Yasmin Abaza, James P. Dugan, Valle Gomez G De Soria, Gaurav S Choudhary, Maureen Lane, Wanying Zhao, Ashish Jain, Cole Gallagher, Uwe Platzbecker
Journal: Blood
Blood (2024) 144 (Supplement 1): 3225.
https://doi.org/10.1182/blood-2024-208292
Published: 2024
Journal Articles

Molecular Characterization of Clinical Response in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome Patients Treated with Single Agent Emavusertib

Klaus H. Metzeler, Eric S. Winer, Uwe Platzbecker, Amit Verma, Daniel J. DeAngelo, Stefano R. Tarantolo, David A. Sallman, James Dugan, Stefanie Gröpper, Katharina S. Goetze, Chia-Cheng Li, Wanying Zhao, Maureen Lane, Reinhard von Roemeling, Samantha Carlisle, Anne Weigert, Matthias Böhme, Anne Sophie Kubasch, Guillermo Garcia-Manero
Journal: Blood
Blood (2022) 140 (Supplement 1): 9048–9049.
https://doi.org/10.1182/blood-2022-167477
Published: 2022
Journal Articles

Phase 1b/2 Study of the First-in-Class SUMO-Activating Enzyme Inhibitor TAK-981 in Combination with Monoclonal Antibodies in Patients with Triple-Class Refractory Multiple Myeloma

Sagar Lonial, Stefano R. Tarantolo, Ralph V. Boccia, Habte Yimer, Moshe Y. Levy, Rafat Abonour, Meera Mohan, Vivek Roy, Jeremy T. Larsen, Saulius K. Girnius, Cara A. Rosenbaum, Omar Nadeem, Deborah Berg, Bo Chao, Allison J Berger, Akito Nakamura, Yuhong Zhang, Keli Song, Christine K. Ward, Igor Proscurshim, Shaji Kumar
Journal: Blood
Blood (2021) 138 (Supplement 1): 2742.
https://doi.org/10.1182/blood-2021-148385
Published: 2021
Journal Articles

A Phase 1, Open Label Dose Escalation Trial Evaluating the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of Orally Administered CA-4948 in Patients with Acute Myelogenous Leukemia or Myelodysplastic Syndrome

Guillermo Garcia-Manero, MD, Uwe Platzbecker, Stefano R. Tarantolo, MD, Stefanie Gropper, Chetasi Talati, MD, Katharina S. Götze, James Dugan, MD, Eric S. Winer, MD, Elizabeth Martinez, PhD DHSC, MSN, Christopher Lieberman, Reinhard von Roemeling, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 16.
https://doi.org/10.1182/blood-2020-140889
Published: 2020
Journal Articles

A Phase 2 Study to Assess the Feasibility and Tolerance of the Combination of Elotuzumab, Lenalidomide, and Dexamethasone (ERd) in the Induction, Consolidation, and Maintenance Treatment of Transplant-Eligible Patients Newly Diagnosed with Multiple Myeloma (MM)

Jesus G. Berdeja, MD, Tara K. Gregory, MD, Suman Kambhampati, MD, Bertrand M. Anz, III, MD, Stefano R. Tarantolo, MD, Anthony A. Meluch, MD, Jeffrey V. Matous, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 603.
https://doi.org/10.1182/blood-2019-130277
Published: 2019
Journal Articles

Phase 1b Study of TRU-016, an Anti-CD37 SMIP™ Protein, in Combination with Rituximab and Bendamustine in Relapsed Indolent Lymphoma

Ajay K. Gopal, MD, Stefano R Tarantolo, Naresh Bellam, MD, MPH, Tatyana Feldman, MD, Anthony R Mato, MD, Damian J Green, MD, Melissa Griffin, Scott Stromatt, MD, Andre Goy, MD
Journal: Blood
Blood (2012) 120 (21): 3678.
https://doi.org/10.1182/blood.V120.21.3678.3678
Published: 2012
Journal Articles

Factors Affecting the Development of Atrial Fibrillation and Atrial Flutter (AF) Following Autologous Hematopoietic Stem Cell Transplantation (auto-HSCT).

Mary Lee H. Villanueva, MD, Fausto R. Loberiza, MD, MS, James O. Armitage, MD, Robert G. Bociek, MD, Apar Kishor Ganti, MD, James C. Lynch, PhD, Farhan Majeed, MD, Stefano R. Tarantolo, MD, Jo Torrey, RN, BSN, Julie M. Vose, MD, Philip J. Bierman, MD
Journal: Blood
Blood (2005) 106 (11): 1754.
https://doi.org/10.1182/blood.V106.11.1754.1754
Published: 2005
Journal Articles

Vincristine-Laden Platelets Can Improve Platelet Counts in Patients with Refractory Thrombocytopenia.

Apar Kishor Ganti, MD, Stefano R. Tarantolo, MD, Lynette M. Smith, MS, Anne Kessinger, MD, James D. Landmark, MD
Journal: Blood
Blood (2004) 104 (11): 3640.
https://doi.org/10.1182/blood.V104.11.3640.3640
Published: 2004
Journal Articles

Decreased immune functions of blood cells following mobilization with granulocyte colony-stimulating factor: association with donor characteristics

Shantaram S. Joshi, James C. Lynch, Steve Z. Pavletic, Stefano R. Tarantolo, Samuel J. Pirruccello, Anne Kessinger, Michael R. Bishop
Journal: Blood
Blood (2001) 98 (6): 1963–1970.
https://doi.org/10.1182/blood.V98.6.1963
Published: 2001
Journal Articles

A randomized, double-blind trial of filgrastim (granulocyte colony-stimulating factor) versus placebo following allogeneic blood stem cell transplantation

Michael R. Bishop, Stefano R. Tarantolo, Robert B. Geller, James C. Lynch, Philip J. Bierman, Z. Steven Pavletic, Julie M. Vose, Susan Kruse, Suzanne P. Dix, Mary E. Morris, James O. Armitage, Anne Kessinger
Journal: Blood
Blood (2000) 96 (1): 80–85.
https://doi.org/10.1182/blood.V96.1.80
Published: 2000